Go Local Guru Web Search

  1. Ads

    related to: dana farber oncology portal

Search results

  1. Results from the Go Local Guru Content Network
  2. Dana–Farber Cancer Institute - Wikipedia

    en.wikipedia.org/wiki/DanaFarber_Cancer_Institute

    The DanaFarber/Harvard Cancer Center is the largest National Cancer Institute (NCI) designated Comprehensive Cancer Center in the nation. Founded in 1997, DF/HCC is an inter-institutional research enterprise that unites all of the cancer research efforts of the Harvard affiliated community.

  3. Sidney Farber - Wikipedia

    en.wikipedia.org/wiki/Sidney_Farber

    Sidney Farber (September 30, 1903 – March 30, 1973) was an American pediatric pathologist. He is regarded as the father of modern chemotherapy for his work using folic acid antagonists to combat leukemia, which led to the development of other chemotherapeutic agents against other malignancies.

  4. James D. Griffin (oncologist) - Wikipedia

    en.wikipedia.org/wiki/James_D._Griffin_(oncologist)

    James D. Griffin is an American physician-scientist. He is currently Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at DanaFarber Cancer Institute, and Director of Medical Oncology at Brigham and Women's Hospital.

  5. Benjamin L. Ebert - Wikipedia

    en.wikipedia.org/wiki/Benjamin_L._Ebert

    Benjamin Levine Ebert is the Chair of Medical Oncology at the DanaFarber Cancer Institute and the George P. Canellos, MD and Jean S. Canellos Professor of Medicine at Harvard Medical School. Early life and education. Ebert was born in Boston Lying-In Hospital to parents Michael and Ellen Ebert.

  6. Catherine J. Wu - Wikipedia

    en.wikipedia.org/wiki/Catherine_J._Wu

    Catherine J. Wu is an American physician-scientist who studies oncology. She is a Professor of Medicine and Chief of Division of Stem Cell Transplantation and Cellular Therapies at the DanaFarber Cancer Institute. Her research focuses on longitudinal studies of patients with chronic lymphocytic leukemia (CLL).

    • Arizona abortion ruling reactions and Dana-Farber Cancer Institute retractions: Morning Rundown
      Arizona abortion ruling reactions and Dana-Farber Cancer Institute retractions: Morning Rundown
      aol.com
    • Entertainment News & Latest Celebrity Headlines
      Entertainment News & Latest Celebrity Headlines
      aol.com
    • DWTS' Sasha Farber, Emma Slater: Sharna Burgess and BAG Are 'Fully in Love'
      aol.com
  7. Alan D'Andrea - Wikipedia

    en.wikipedia.org/wiki/Alan_D'Andrea

    Alan D. D'Andrea is an American cancer researcher and the Fuller American Cancer Society Professor of Radiation Oncology at Harvard Medical School. D'Andrea's research at the Dana Farber Cancer Institute focuses on chromosome instability and cancer susceptibility.

  8. Mary-Ellen B. Taplin - Wikipedia

    en.wikipedia.org/wiki/Mary-Ellen_B._Taplin

    Mary-Ellen Taplin (born 1960), is a research oncologist at Dana Farber Cancer Institute and Brigham and Women's Hospital in Harvard's Longwood Medical and Academic Area.

  9. Toni Choueiri - Wikipedia

    en.wikipedia.org/wiki/Toni_Choueiri

    Toni K. Choueiri is a Lebanese American medical oncologist and researcher. He is the Jerome and Nancy Kohlberg Professor of Medicine at Harvard Medical School and Director of the Lank Center for Genitourinary Oncology at the DanaFarber Cancer Institute. His work has led to the establishment of several novel drugs (cabozantinib, avelumab ...

  10. Beth Overmoyer - Wikipedia

    en.wikipedia.org/wiki/Beth_Overmoyer

    In 2007, Overmoyer moved to the DanaFarber Cancer Institute, where she established the Inflammatory Breast Cancer Program in 2009. Inflammatory breast cancer is a rare, fast-growing disease, which causes the lymph vessels within breast skins to become clogged with tumor cells.

  11. Loren D. Walensky - Wikipedia

    en.wikipedia.org/wiki/Loren_D._Walensky

    Loren David Walensky is an American physician-scientist and pediatric oncologist at the DanaFarber Cancer Institute since 2003 and a professor of pediatrics at the DanaFarber/Harvard Cancer Center. He researches peptides and oncogenic pathways. In 2013, Walensky became director of the joint MD/PhD program at Harvard Medical School.